ArticlePloS one2025

Retraction: Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of Colorectal Carcinoma.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.